导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -22.34% | 4463/4773 |
| 近一周 | -4.37% | 4966/5462 |
| 近一月 | -11.73% | 5373/5421 |
| 近一季 | -20.31% | 4904/5209 |
| 近半年 | -22.26% | 4509/4920 |
| 近一年 | -19.01% | 3896/4366 |
| 近两年 | 37.88% | 1979/2954 |
| 近三年 | 12.08% | 1695/2253 |
| 成立以来 | 28.81% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.54% 3274/4961 |
0.76% 3133/5312 |
- - |
- - |
| 2025 | 38.99% 848/4813 |
8.19% 454/3635 |
-4.54% 3479/4076 |
44.53% 630/4524 |
-6.88% 3740/4813 |
| 2024 | 12.00% 1281/3463 |
-4.07% 1604/2808 |
-2.73% 1235/3014 |
21.80% 546/3129 |
-1.46% 1711/3463 |
| 2023 | -18.53% 1814/2656 |
0.78% 1699/2280 |
-1.74% 521/2385 |
-11.88% 2096/2515 |
-6.64% 1855/2655 |
| 2022 | -31.66% 1663/2207 |
-21.47% 1629/1919 |
17.67% 120/2016 |
-23.31% 1966/2113 |
-3.57% 1856/2208 |
| 2021 | - - |
- - |
- - |
2.28% 439/1466 |
8.92% 133/1822 |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 易方达中证智能电动汽车ETF VS. 长安沪深300非周期A(740101) |